期刊文献+

慢性心力衰竭患者肾素、血管紧张素及醛固酮活性变化 被引量:6

Changes of renin,angiotensin,and aldosterone activity in patients with chronic heart failure
下载PDF
导出
摘要 目的 :探讨充血性心力衰竭 (CHF)患者肾素、血管紧张素和醛固酮活性的变化。方法 :采用放免法测定收缩压 (pSB) <13.33kPa的CHF患者 (A组 ,2 8例 ) ,pSB>13.33kPa的CHF患者 (B组 ,32例 )及健康人 (对照组 ,2 5例 )血浆肾素活性 (PRA)、血管紧张素Ⅱ (AngⅡ )及醛固酮 (ALD)水平。结果 :A组及B组血浆PRA、AngⅡ和ALD均明显高于对照组 ,差异有统计学意义 (P <0 .0 5或 0 .0 1) ;A组血清钠、pSB及脉压 /pSB显著低于对照组 ,差异有统计学意义 (P <0 .0 5或 0 .0 1) ;A组血浆PAR、AngⅡ和ALD高于B组 ,差异有统计学意义 (P <0 .0 5或 0 .0 1) ;A组血清钠、pSB及脉压 /pSP显著低于B组 ,差异有统计学意义 (P <0 .0 5或 0 .0 1) ;CHF患者脉压 /pSB与血浆AngⅡ及ALD呈负相关 (r=- 0 .4 6 2 ,P <0 .0 1;r=- 0 .4 4 3,P <0 .0 1)。结论 :CHF患者体内肾素 -血管紧张素 -醛固酮系统活性增高 ,且pSB<13.33kPa者高于pSB>13. Aim: To investigate the changes of renin,angiotensin,and aldosterone activity in patients with congestive heart failure(CHF) Methods: A total of 60 patients were divided into two groups according to their systolic blood pressure(p SB):①patients with p SB<13.33 kPa (group A,n=28); ②patients with p SB>.33 kPa (group B,n=32).Normal control group included 25 health people. Plasmal levels of renin, angiotensin,and aldosterone (PRA,AngⅡ and ALD) were measured by radio-immunity assay(RIA). Results: Plasma levels of PRA, AngⅡ,and ALD in group A and B were significantly higher than those of control group(P<0.05 or 0.01),especially in group A (compared with group B, P< 0.05 or 0.01).Group A had lower serum sodium, p SB,and pulse pressure/systolic pressure compared with group B (P< 0.05 or 0.01). There was a negative relationship between the pulse pressure/systolic pressure and the AngⅡ and ALD levels(r=-0.462,P<0.01; r=-0.443,P<0.01)in CHF patients. Conclusion: Renin,angiotensin,and aldosterone activity increase in CHF patients, especially in the patients with lower p SB less than 13.33 kPa.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第6期982-984,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省自然科学基金资助项目 0 3 2 44 10 13 2
关键词 心力衰竭 血压 肾素-血管紧张素-醛固酮系统 heart failure blood pressure renin-angiotensin-aldosterone system
  • 相关文献

参考文献8

  • 1Lopes ME, Le Corvoisier P, Tabet JY,et al. Aldosterone and its antagonists in heart failure. Presse Med, 2003,32(2):79
  • 2Soberman J, Chafin CC, Weber KT. Aldosterone antagonists in congestive heart failure. Curr Opin Investig Drugs,2002,3(7):1 024
  • 3Palmieri EA, Biondi B, Fazio S. Aldosterone receptor blockade in the management of heart failure. Heart Fail Rev,2002,7(2):205
  • 4Stevenson L W, Perloff J K. The limited reliability of physical signs for the estimating hemodynamics in chronic heart failure. JAMA, 1989,261(6):884
  • 5Dries DL, Strong MH, Cooper RS,et al. Efficacy of angiotensinconverting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. J Am Coll Cardiol,2002,40(2):311
  • 6Jessup M.Aldosterone blockade and heart failure. N Engl J Med,2003,348(14):1 380
  • 7Pitt B,Zannad F,Remme WJ,et al. The effect of Spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med,1999,341(10): 709
  • 8吴志峰,祝善俊,孟素荣,李隆贵,黄坚,袁林贵.心功能障碍患者心肌组织及血浆肾素-血管紧张素系统、心钠素改变的临床意义[J].中华心血管病杂志,1996,24(1):9-11. 被引量:28

二级参考文献3

  • 1Tan L B,J Hypertens,1992年,10卷,增刊,S31页
  • 2温绍君,放射免疫学杂志,1990年,3卷,78页
  • 3汤健,心钠素,1989年

共引文献28

同被引文献67

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部